EARLY ONSET ALZHEIMER DISEASE
Clinical trials for EARLY ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental gene therapy targets Alzheimer's in High-Risk patients
Disease control CompletedThis early-stage study tested a gene therapy called LX1001 in 15 people with a specific genetic form of Alzheimer's (APOE4 homozygotes). The main goal was to check safety and side effects over 52 weeks. Participants had mild cognitive impairment or mild to moderate dementia due t…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
Blood test breakthrough could spot Alzheimer's early
Diagnosis CompletedThis study tested a new blood test to see if it can help diagnose Alzheimer's disease. Researchers measured two specific markers in the blood of 200 people, including those with Alzheimer's and healthy volunteers, over 24 months. The goal was to see if these markers can reliably …
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated May 20, 2026 11:55 UTC